Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

NCT01755195 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

NIH

Sponsor class

Conditions

Refractory Soft Tissue Sarcomas

Interventions

DRUG: Cabozantinib

Sponsor

National Cancer Institute (NCI)